Idarubicin-transarterial chemoembolization combined with gemcitabine plus cisplatin for unresectable intrahepatic cholangiocarcinoma

Figure 3 Effect of different treatment groups on tumor volume in tumor-bearing mice. A: Bar graph showing tumor growth over 15 days; B: Images of excised tumors from mice in different treatment groups. ^aP < 0.05. ^bP < 0.01. ^cP < 0.001. ^dP < 0.0001. IDA: Idarubicin; GP: Gemcitabine and cisplatin.